CathWorks Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 84

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Latest Deal Amount
  • $585M

  • Investors
  • 12

CathWorks General Information

Description

Developer of a computational science platform designed to optimize therapy decisions. The company's platform provides a functional flow reserve for processing visual information and automatic multi-layered algorithms to improve the utilization of coronary angiography data to ratify measurement-based medicine, enabling healthcare providers to optimize cath lab throughput.

Contact Information

Website
www.cath.works
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3 Rapaport Street
  • Kfar-Saba 4465141
  • Israel
+972
Primary Industry
Decision/Risk Analysis
Vertical(s)
HealthTech
Corporate Office
  • 3 Rapaport Street
  • Kfar-Saba 4465141
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CathWorks Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 12-Jul-2022 $585M Announced Generating Revenue
10. Later Stage VC 12-Jul-2022 Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Later Stage VC (Series D) 16-Dec-2020 Completed Generating Revenue
7. Debt - PPP 29-Jun-2020 Completed Generating Revenue
6. Grant 29-May-2019 Completed Generating Revenue
5. Later Stage VC (Series C) 04-Feb-2019 Completed Generating Revenue
4. Accelerator/Incubator 01-Jun-2018 Completed Generating Revenue
3. Later Stage VC 01-Jan-2018 $23.6M Completed Generating Revenue
2. Early Stage VC (Series B) 02-Oct-2017 $16.3M $23.6M Completed Generating Revenue
To view CathWorks’s complete valuation and funding history, request access »

CathWorks Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred D
Preferred C
Preferred B
Preferred A4
Preferred A3
Preferred A2
Preferred A1 948 $0.010000 $150.84 $150.84 1x $150.84 0.53%
Preferred A 30,811 $0.010000 $189 $189 1x $189 17.27%
To view CathWorks’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CathWorks Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a computational science platform designed to optimize therapy decisions. The company's platform provides a
Decision/Risk Analysis
Kfar-Saba, Israel
84 As of 2024

Mountain View, CA
 

Amsterdam, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CathWorks Competitors (5)

One of CathWorks’s 5 competitors is HeartFlow, a Venture Capital-Backed company based in Mountain View, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HeartFlow Venture Capital-Backed Mountain View, CA
Philips Corporation Amsterdam, Netherlands
Opsens Corporate Backed or Acquired Quebec, Canada
Boston Scientific Corporation Marlborough, MA
Abbott Corporation North Chicago, IL
You’re viewing 5 of 5 competitors. Get the full list »

CathWorks Patents

  • 122

    Total Documents Applications and Grants

  • Total Patents Families

  • 92

    Granted

  • 28

    Pending

  • Expiring in next 12 mo

CathWorks Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250054628-A1 Post-pci coronary analysis Pending 09-Aug-2023
US-20250049507-A1 Enhanced user interface and crosstalk analysis for vascular index measurement Pending 09-Aug-2023
US-20230252632-A1 System and method for machine-learning based sensor analysis and vascular tree segmentation Pending 10-Feb-2022
US-20240029259-A1 System and method for machine-learning based sensor analysis and vascular tree segmentation Pending 10-Feb-2022
EP-4476685-A1 System and method for machine-learning based sensor analysis and vascular tree segmentation Pending 10-Feb-2022 G06T7/0012
To view CathWorks’s complete patent history, request access »

CathWorks Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CathWorks Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abiomed Corporation Minority
Israel Innovation Authority Government
Ministry of Economy and Industry Government
Deerfield Management Venture Capital Minority
Pura Vida Investments Hedge Fund Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

CathWorks FAQs

  • When was CathWorks founded?

    CathWorks was founded in 2013.

  • Where is CathWorks headquartered?

    CathWorks is headquartered in Kfar-Saba, Israel.

  • What is the size of CathWorks?

    CathWorks has 84 total employees.

  • What industry is CathWorks in?

    CathWorks’s primary industry is Decision/Risk Analysis.

  • Is CathWorks a private or public company?

    CathWorks is a Private company.

  • What is the current valuation of CathWorks?

    The current valuation of CathWorks is .

  • What is CathWorks’s current revenue?

    The current revenue for CathWorks is .

  • How much funding has CathWorks raised over time?

    CathWorks has raised $159M.

  • Who are CathWorks’s investors?

    Abiomed, Israel Innovation Authority, Ministry of Economy and Industry, Deerfield Management, and Pura Vida Investments are 5 of 12 investors who have invested in CathWorks.

  • Who are CathWorks’s competitors?

    HeartFlow, Philips, Opsens, Boston Scientific, and Abbott are competitors of CathWorks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »